advancing innovation to save lives

GHTC honors Sen. Coons, Cong. Cole, and the dapivirine microbicide ring with Innovating for Impact Awards

GHTC’s hosted the Innovating for Impact Awards to celebrate US commitment to global health research and development (R&D) and recognize the policymakers and partnerships driving progress in global health innovation.
Learn More

The first step

GHTC released a new two-minute video taking viewers on a journey to discover how sustained investments in global health R&D can unlock health and opportunity for people around the world.

Member spotlight

RESULTS performs cutting-edge research and oversight; educates and mobilizes the public, policy makers, and the media; and supports powerful citizenship by training volunteers in advocacy, including on global health.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We are a coalition of more than 25 nonprofit organizations advancing policies to accelerate the creation of new drugs, vaccines, diagnostics, and other health tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity in reach for all people.

Learn more
GHTC issues recommendations for Congress, Administration

GHTC recently released its first annual policy report, which provides recommendations for Congress and the Administration on how to position the United States as the leader in a worldwide movement to strengthen global health R&D.

Learn More
PATH/Doune Porter
GHTC calls for US engagement in innovative effort to bring vaccines to children worldwide

GlaxoSmithKline and Pfizer today announced that they have joined the first Advance Market Commitment (AMC), a unique funding effort to bring pneumococcal vaccines to millions of children worldwide. GHTC commends increased involvement in the AMC and calls on the United States to participate in innovative health financing mechanisms, including a future AMC, to maximize the life-saving potential of immunizations worldwide.

Learn More
View All News & Events

Member Event

PATH/Gabe Bienczycki
Webinar: Exploring the implications of the delamanid phase III and STREAM trial results
Learn More

Member Event

PATH/Gabe Bienczycki
5th Global Forum on TB Vaccines
Stop TB Partnership, Aeras, TBVI, THSTi...
Learn More
View All Events
PATH/Rocky Prajapati
Research Roundup: Environmental threat of AMR, obstacles with the dengue vaccine, and an Army-developed Zika candidate

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
Photo courtesy Bill & Melinda Gates Foundation/Lou Linwei
Research Roundup: A mosquito deliverer, the "fake" medicine crisis, and a promising typhoid vaccine

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week

Read More
View Breakthroughs Blog

Our members work to improve health worldwide